Marilyn McLaughlin

Statistics

Publications

Citations

981

H-Index

Active since

1974

Affiliations

Centro de Investigación Biomédica en Red de Cáncer(Current)

Marilyn McLaughlin is an author at Centro de Investigación Biomédica en Red de Cáncer specializing in medicine, pharmacology, and cancer pharmacology.

Publications per year

1974–2019

Publications

Neratinib after trastuzumab-based adjuvant therapy in HER2-positive breast cancer (ExteNET): 5-year analysis of a randomised, double-blind, placebo-controlled, phase 3 trial

Miguel Martín, Frankie A. Holmes, Bent Ejlertsen et al. · The Lancet Oncology · 2017 · 589 citations

Medicine, Oncology, Pharmacology +15

SEASONAL VARIATIONS IN SERUM 25-HYDROXYCHOLECALCIFEROL IN HEALTHY PEOPLE

Marilyn McLaughlin, Angela Fairney, Eva P. Lester et al. · The Lancet · 1974 · 176 citations

Medicine, Pharmacokinetics, Pharmacology +4

Targeting protein disulfide isomerase with the flavonoid isoquercetin to improve hypercoagulability in advanced cancer

Jeffrey I. Zwicker, Benjamin L. Schlechter, Jack D. Stopa et al. · JCI Insight · 2019 · 170 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

Growth Hormone (GH)-Releasing Factor Does Not Regulate GH Release or GH mRNA Levels in GH<sub>3</sub>Cells*

Füsûn N. Zeytin, Gregory Gick, Paul Brazeau et al. · Endocrinology · 1984 · 46 citations

Life Sciences, Cell Biology, Endocrinology +16

1–4 of 4